•
Dec 31, 2012

Cocrystal Pharma Q4 2012 Earnings Report

Total Revenue
$2.47M
Previous year: $12.7M
-80.6%
EPS
-$0.06
Previous year: -$0.04
+50.0%
Gross Profit
$1.72M
Previous year: -$304K
-666.9%
Cash and Equivalents
$4.72M
Previous year: $35.4K
+13236.9%
Free Cash Flow
-$1.64M
Total Assets
$7.24M
Previous year: $7.55M
-4.1%

Cocrystal Pharma

Cocrystal Pharma